Therefore, there is a need for safe and effective AChE inhibitors that can halt the progression of the disease at its initial stage, prevent neurodegeneration, or improve cognitive impairment to reduce the social and financial burden of caring for AD patients and enhance their quality of life [22]. The gene discussed is ACHE; the disease is Cognitive impairment.